Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Moss

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Pediatric Pulmonology|October 14, 2009
Cystic fibrosis HRCT scores correlate strongly with Pseudomonas infectionTerry E Robinson, Ann N Leung, Xiaorong Chen, et al.
Plos One|April 19, 2017
The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurementsJessica E Char, Colleen Dunn, Zoe Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosisRabindra Tirouvanziam, Carol K Conrad, Teodoro Bottiglieri, et al.
Mycopathologia|August 9, 2017
Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus BiofilmRajesh Anand, Richard B Moss, Gabriele Sass, et al.
Chest|October 21, 2005
Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysisTerry E Robinson, Michael L Goris, Hongyun J Zhu, et al.
Journal of Digital Imaging|December 13, 2005
Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chestRaman Venkatraman, Raghav Raman, Bhargav Raman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2012
Long term effects of denufosol tetrasodium in patients with cystic fibrosisFelix Ratjen, Todd Durham, Tomas Navratil, et al.
Pulmonary Therapy|September 23, 2020
Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive MutationsJoseph M Pilewski, Kris De Boeck, Jerry A Nick, et al.
Mycopathologia|November 9, 2016
Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with PseudomonasHasan Nazik, Richard B Moss, Vyshnavi Karna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 17, 2021
Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-AnalysisBrian C M Li, Sung Moon Huh, Miguel D Prieto, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Pediatric Pulmonology|October 14, 2009
Cystic fibrosis HRCT scores correlate strongly with Pseudomonas infectionTerry E Robinson, Ann N Leung, Xiaorong Chen, et al.
Plos One|April 19, 2017
The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurementsJessica E Char, Colleen Dunn, Zoe Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosisRabindra Tirouvanziam, Carol K Conrad, Teodoro Bottiglieri, et al.
Mycopathologia|August 9, 2017
Small Colony Variants of Pseudomonas aeruginosa Display Heterogeneity in Inhibiting Aspergillus fumigatus BiofilmRajesh Anand, Richard B Moss, Gabriele Sass, et al.
Chest|October 21, 2005
Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysisTerry E Robinson, Michael L Goris, Hongyun J Zhu, et al.
Journal of Digital Imaging|December 13, 2005
Fully automated system for three-dimensional bronchial morphology analysis using volumetric multidetector computed tomography of the chestRaman Venkatraman, Raghav Raman, Bhargav Raman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 12, 2012
Long term effects of denufosol tetrasodium in patients with cystic fibrosisFelix Ratjen, Todd Durham, Tomas Navratil, et al.
Pulmonary Therapy|September 23, 2020
Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive MutationsJoseph M Pilewski, Kris De Boeck, Jerry A Nick, et al.
Mycopathologia|November 9, 2016
Are Cystic Fibrosis Aspergillus fumigatus Isolates Different? Intermicrobial Interactions with PseudomonasHasan Nazik, Richard B Moss, Vyshnavi Karna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 17, 2021
Biomarkers for the Diagnosis of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: A Systematic Review and Meta-AnalysisBrian C M Li, Sung Moon Huh, Miguel D Prieto, et al.
Pageof 7